You just read:

Theratechnologies Announces Comparative PK Data on the Intramuscular and Intravenous Administration of the Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab

News provided by

Theratechnologies Inc.

15 Feb, 2017, 19:00 ET